Table 4: Subgroups for influenza and pneumococcal vaccines.
|
|
Influenza |
Pneumococcal (age ≥ 65 years) |
Pneumococcal (High Risk < 65 years) |
|||
|
Subgroups |
Baseline |
Follow-up |
Baseline |
Follow-up |
Baseline |
Follow-up |
|
Age (years) |
|
|
|
|
|
|
|
< 65 years |
33,413/77,381 (43.2%) |
38,134/74,566 (51.1%) |
0 |
0 |
7866/26807 (29.3%) |
11,787/30,371 (38.8%) |
|
65 - 80 years |
20,938/29,226 (71.6%) |
21,319/27,357 (77.9%) |
11088/36751 (30.2%) |
21871/37895 (57.5%) |
0 |
0 |
|
> 80 years |
5,020/6,626 (75.8%) |
4,532/5,580 (81.2%) |
2,202/8,049 (27.4%) |
3,853/6,600 (58.4%) |
0 |
0 |
|
Sex |
|
|
|
|
|
|
|
Female |
36,454/68,931 (52.9%) |
39,688/66,071 (60.1%) |
7,810/26,823 (29.1%) |
15,212/26,675 (57.0%) |
4,105/14,935 (27.5%) |
6,275/17,292 (36.3%) |
|
Male |
22,917/44,302 (51.7%) |
24,297/41,432 (58.6%) |
5,480/17,977 (30.5%) |
10,512/17,820 (59.0%) |
3,761/11,872 (31.7%) |
5,512/13,079 (42.1%) |
|
Race |
|
|
|
|
|
|
|
White |
41,318/74,486 (55.5%) |
44,419/70,414 (63.1%) |
10,165/33,077 (30.7%) |
19,434/32,673 (59.5%) |
4,259/16,373 (26.0%) |
6,505/18,319 (35.5%) |
|
Black or African American |
13,462/28,514 (47.2%) |
14,453/27,639 (52.3%) |
2,450/9,243 (26.5%) |
5,161/9,504 (54.3%) |
2,931/8,365 (35.0%) |
4,346/9,747 (44.6%) |
|
Asian/Pacific Islander |
1,803/3,652 (49.4%) |
2,334/4,056 (57.5%) |
306/897 (34.1%) |
518/965 (53.7%) |
236/628 (37.6%) |
372/850 (43.8%) |
|
Other, reported |
1,621/3,823 (42.4%) |
1,544/2,999 (51.5%) |
204/861 (23.7%) |
309/673 (45.9%) |
276/857 (32.2%) |
363/870 (41.7%) |
|
Insurance |
|
|
|
|
|
|
|
Government |
23,405/33,678 (69.5%) |
25,261/34,055 (74.2%) |
9,831/31,727 (31.0%) |
19,571/33,081 (59.2%) |
1,424/4,098 (34.7%) |
2,313/4,985 (46.4%) |
|
Private |
28,822/66,287 (43.5%) |
30,841/60,017 (51.4%) |
825/3,546 (23.3%) |
1,380/2,996 (46.1%) |
5,649/20,032 (28.2%) |
8,111/21,572 (37.6%) |
|
Multiple |
6,797/11,479 (59.2%) |
7,505/11,808 (63.6%) |
2,622/9,405 (27.9%) |
4,758/8,314 (57.2%) |
680/2,056 (33.1%) |
1,155/3,033 (38.1%) |
|
None |
347/1,789 (19.4%) |
378/1,623 (23.3%) |
12/122 (9.8%) |
15/104 (14.4%) |
113/621 (18.2%) |
208/781 (26.6%) |
|
Cancer history |
|
|
|
|
|
|
|
Yes |
10,244/14,544 (70.4%) |
11,082/14,469 (76.6%) |
3,811/11,805 (32.3%) |
7,508/11,883 (63.2%) |
303/6,063 (5.0%) |
474/6,299 (7.5%) |
|
No |
49,127/98,689 (49.8%) |
52,903/93,034 (56.9%) |
9,479/32,995 (28.7%) |
18,216/32,612 (55.9%) |
7,563/20,744 (36.5%) |
11,313/24,072 (47.0%) |
|
Diabetes |
|
|
|
|
|
|
|
Yes |
13,344/20,079 (66.5%) |
13,428/18,757 (71.6%) |
3,380/11,039 (30.6%) |
6,629/10,722 (61.8%) |
6,008/11,830 (50.8%) |
7,448/11,868 (62.8%) |
|
No |
46,027/93,154 (49.4%) |
50,557/88,746 (57.0%) |
9,910/33,761 (29.4%) |
19,095/33,773 (56.5%) |
1,858/14,977 (12.4%) |
4,339/18,503 (23.5%) |
|
Chronic lung disease |
|
|
|
|
|
|
|
Yes |
5,802/8,652 (67.1%) |
6,433/8,923 (72.1%) |
1,707/4,784 (35.7%) |
3,103/4,920 (63.1%) |
1,360/3,305 (41.1%) |
2,512/4,890 (51.4%) |
|
No |
53,569/104,581 (51.2%) |
57,552/98,580 (58.4%) |
11,583/40,016 (28.9%) |
22,621/39,575 (57.2%) |
6,506/23,502 (27.7%) |
9,275/25,481 (36.4%) |